Search Results - "ALAGOZ, Oguzhan"

Validating agent-based simulation model of hospital-associated Clostridioides difficile infection using primary hospital data by Scaria, Elizabeth, Safdar, Nasia, Alagoz, Oguzhan

“…As agent-based models (ABMs) are increasingly used for modeling infectious diseases, model validation is becoming more crucial. In this study, we present an…”
Get full text

Modeling secrecy and deception in a multiple-period attacker–defender signaling game by Zhuang, Jun, Bier, Vicki M., Alagoz, Oguzhan

“…In this paper, we apply game theory to model strategies of secrecy and deception in a multiple-period attacker–defender resource-allocation and signaling game…”
Get full text

The impact of vaccination to control COVID-19 burden in the United States: A simulation modeling approach by Alagoz, Oguzhan, Sethi, Ajay K, Patterson, Brian W, Churpek, Matthew, Alhanaee, Ghalib, Scaria, Elizabeth, Safdar, Nasia

“…Introduction Vaccination programs aim to control the COVID-19 pandemic. However, the relative impacts of vaccine coverage, effectiveness, and capacity in the…”
Get full text

State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3 by Siebert, Uwe, MD, MPH, MSc, ScD, Alagoz, Oguzhan, PhD, MS, Bayoumi, Ahmed M., MD, MSc, Jahn, Beate, PhD, Owens, Douglas K., MD, MS, Cohen, David J., MD, MS, Kuntz, Karen M., ScD

“…Abstract State-transition modeling is an intuitive, flexible, and transparent approach of computer-based decision-analytic modeling including both Markov model…”
Get full text

Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study by Rutter, Carolyn M, Kim, Jane J, Meester, Reinier G S, Sprague, Brian L, Burger, Emily A, Zauber, Ann G, Ergun, Mehmet Ali, Campos, Nicole G, Doubeni, Chyke A, Trentham-Dietz, Amy, Sy, Stephen, Alagoz, Oguzhan, Stout, Natasha, Lansdorp-Vogelaar, Iris, Corley, Douglas A, Tosteson, Anna N A

“…Patients who receive an abnormal cancer screening result require follow-up for diagnostic testing, but the time to follow-up varies across patients and…”
Get full text

Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer by Hajjar, Ali, Ergun, Mehmet A, Alagoz, Oguzhan, Rampurwala, Murtuza

“…Adjuvant paclitaxel and trastuzumab has been shown to be an effective regimen with low risk of cancer recurrence and treatment-related toxicities in…”
Get full text

Optimal Breast Biopsy Decision-Making Based on Mammographic Features and Demographic Factors by Chhatwal, Jagpreet, Alagoz, Oguzhan, Burnside, Elizabeth S.

“…Breast cancer is the most common non-skin cancer affecting women in the United States, where every year more than 20 million mammograms are performed. Breast…”
Get full text

Benefits, Harms, and Costs for Breast Cancer Screening After US Implementation of Digital Mammography by STOUT, Natasha K, LEE, Sandra J, HUI HUANG, HUBBARD, Rebecca A, MIGLIORETTI, Diana L, MUNSELL, Mark F, TRENTHAM-DIETZ, Amy, VAN RAVESTEYN, Nicolien T, TOSTESON, Anna N. A, MANDELBLATT, Jeanne S, SCHECHTER, Clyde B, KERLIKOWSKE, Karla, ALAGOZ, Oguzhan, BERRY, Donald, BUIST, Diana S. M, CEVIK, Mucahit, CHISHOLM, Gary, DE KONING, Harry J

“…Compared with film, digital mammography has superior sensitivity but lower specificity for women aged 40 to 49 years and women with dense breasts. Digital has…”
Get full text

Breast cancer risk for women with diabetes and the impact of metformin: A meta‐analysis by Lu, Yifan, Hajjar, Ali, Cryns, Vincent L., Trentham‐Dietz, Amy, Gangnon, Ronald E., Heckman‐Stoddard, Brandy M., Alagoz, Oguzhan

“…Background Diabetes mellitus has been associated with increased breast cancer (BC) risk; however, the magnitude of this effect is uncertain. This study focused…”
Get full text

Reflecting on 20 years of breast cancer modeling in CISNET: Recommendations for future cancer systems modeling efforts by Trentham-Dietz, Amy, Alagoz, Oguzhan, Chapman, Christina, Huang, Xuelin, Jayasekera, Jinani, van Ravesteyn, Nicolien T, Lee, Sandra J, Schechter, Clyde B, Yeh, Jennifer M, Plevritis, Sylvia K, Mandelblatt, Jeanne S

“…Since 2000, the National Cancer Institute’s Cancer Intervention and Surveillance Modeling Network (CISNET) modeling teams have developed and applied…”
Get full text

Neighborhood disadvantage and 30-day readmission risk following Clostridioides difficile infection hospitalization by Scaria, Elizabeth, Powell, W. Ryan, Birstler, Jen, Alagoz, Oguzhan, Shirley, Daniel, Kind, Amy J. H, Safdar, Nasia

“…Abstract Background Clostridioides difficile infection (CDI) is commonly associated with outcomes like recurrence and readmission. The effect of social…”
Get full text

What is the optimal threshold at which to recommend breast biopsy? by Burnside, Elizabeth S, Chhatwal, Jagpreet, Alagoz, Oguzhan

“…A 2% threshold, traditionally used as a level above which breast biopsy recommended, has been generalized to all patients from several specific situations…”
Get full text

Changes to physician and nurse time burdens when caring for patients under contact precautions by Barker, Anna K., BA, Codella, James, PhD, Ewers, Tola, MS, PhD, Dundon, Adam, MS, Alagoz, Oguzhan, PhD, Safdar, Nasia, MD, PhD

“…Contact precautions are complex behavioral interventions. To better understand barriers to compliance, we conducted a prospective study that compared the time…”
Get full text

Probabilistic Computer Model Developed from Clinical Data in National Mammography Database Format to Classify Mammographic Findings by BURNSIDE, Elizabeth S, DAVIS, Jesse, CHHATWAL, Jagpreet, ALAGOZ, Oguzhan, LINDSTROM, Mary J, GELLER, Berta M, LITTENBERG, Benjamin, SHAFFER, Katherine A, KAHN, Charles E, PAGE, C. David

“…To determine whether a Bayesian network trained on a large database of patient demographic risk factors and radiologist-observed findings from consecutive…”
Get full text

Personalized Disease Screening Decisions Considering a Chronic Condition by Hajjar, Ali, Alagoz, Oguzhan

“…Clinical practice guidelines do not sufficiently address the needs of patients with chronic conditions as these guidelines focus on single disease management…”
Get full text

Using Collaborative Simulation Modeling to Develop a Web-Based Tool to Support Policy-Level Decision Making About Breast Cancer Screening Initiation Age by Burnside, Elizabeth S., Lee, Sandra J., Bennette, Carrie, Near, Aimee M., Alagoz, Oguzhan, Huang, Hui, van den Broek, Jeroen J., Kim, Joo Yeon, Ergun, Mehmet A., van Ravesteyn, Nicolien T., Stout, Natasha K., de Koning, Harry J., Mandelblatt, Jeanne S.

“…Background: There are no publicly available tools designed specifically to assist policy makers to make informed decisions about the optimal ages of breast…”
Get full text

Comparison of Logistic Regression and Artificial Neural Network Models in Breast Cancer Risk Estimation by Ayer, Turgay, Chhatwal, Jagpreet, Alagoz, Oguzhan, Kahn, Charles E., Woods, Ryan W., Burnside, Elizabeth S.

Get full text

Comparison of Logistic Regression and Artificial Neural Network Models in Breast Cancer Risk Estimation1 by Ayer, Turgay, Chhatwal, Jagpreet, Alagoz, Oguzhan, Kahn, Charles E., Woods, Ryan W., Burnside, Elizabeth S.

“…Computer models in medical diagnosis are being developed to help physicians differentiate between healthy patients and patients with disease. These models can…”
Get full text

OR Forum-A POMDP Approach to Personalize Mammography Screening Decisions by Ayer, Turgay, Alagoz, Oguzhan, Stout, Natasha K.

“…Breast cancer is the most common nonskin cancer and the second leading cause of cancer death in U.S. women. Although mammography is the most effective modality…”
Get full text

Interventions to Reduce the Incidence of Hospital-Onset Clostridium difficile Infection: An Agent-Based Modeling Approach to Evaluate Clinical Effectiveness in Adult Acute Care Hospitals by Barker, Anna K, Alagoz, Oguzhan, Safdar, Nasia

“…Despite intensified efforts to reduce hospital-onset Clostridium difficile infection (HO-CDI), its clinical and economic impacts continue to worsen. Many…”
Get full text